Successful rechallenge with cetuximab after an infusion related reaction to panitumumab in a patient with locally advanced rectal cancer

Incidence of infusion related reaction (IR) is more common with cetuximab (Cmab) than with panitumumab (Pmab). Although little is known about rechallenge IR with monoclonal antibodies, we experienced a successful rechallenge to Cmab after IR to Pmab. A 67-year-old female patient was scheduled for ch...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Int Cancer Conf J
Hauptverfasser: Yokokawa, Hideyuki, Kono, Teppei, Shidei, Hiroaki, Oyama, Kunihiro, Ito, Yoshitomo, Imaizumi, Rie, Miyano, Yutaka, Shiozawa, Shunichi, Yoshimatsu, Kazuhiko
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer Singapore 2020
Schlagworte:
Case Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7797389/
https://ncbi.nlm.nih.gov/pubmed/33489709
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-020-00455-x
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge